首页 | 本学科首页   官方微博 | 高级检索  
     

非小细胞肺癌脑膜转移的诊疗进展
引用本文:张 帅,别志欣. 非小细胞肺癌脑膜转移的诊疗进展[J]. 中国癌症杂志, 2017, 27(7): 593-600. DOI: 10.19401/j.cnki.1007-3639.2017.07.012
作者姓名:张 帅  别志欣
作者单位:北京医院国家老年医学中心肿瘤内科,北京 100730
摘    要:脑膜转移是非小细胞肺癌的严重并发症,其临床表现不特异,主要包括脑实质受累、颅神经及脊髓、脊神经根刺激症状。诊断主要依据肿瘤病史、临床表现、影像学及脑脊液检测。EGFR-TKIs等靶向治疗药物应用于选择人群可能存在生存获益,但目前其总体治疗效果仍不满意,预后差。本文就非小细胞肺癌脑膜转移的流行病学、病理生理、临床表现、诊断方法及治疗疗效的研究进展进行综述。

关 键 词:非小细胞肺癌  脑膜转移  诊断  治疗  

Advances in the diagnosis and therapies of leptomeningeal metastasis in non-small cell lung cancer
ZHANG Shuai,BIE Zhixin. Advances in the diagnosis and therapies of leptomeningeal metastasis in non-small cell lung cancer[J]. China Oncology, 2017, 27(7): 593-600. DOI: 10.19401/j.cnki.1007-3639.2017.07.012
Authors:ZHANG Shuai  BIE Zhixin
Affiliation:Department of Medical Oncology, National Center of Gerontology, Beijing Hospital, Beijing 100730, China
Abstract:Leptomeningeal metastasis (LM) is a serious fatal complication of non-small cell lung cancer (NSCLC), which is lack of specificity in clinical manifestations. Symptoms and signs are classically divided into three domains of neurological function: cerebral hemisphere, cranial nerve and spinal cord, and exiting nerve roots. Apart from a clinical suspicion of LM, diagnosis is based on demonstration of cancer in cerebrospinal fluid or radiographic manifestations as revealed by neuraxis imaging. Although the novel agents including targeted therapies such as EGFR-TKIs have conferred a survival benefit in selected NSCLC patients in some studies, the prognosis is still poor. This review focuses on the pathologic physiology, clinical manifestations, diagnosis and therapies of LM in NSCLC.
Keywords:Non-small cell lung cancer  Leptomeningeal metastasis   Diagnosis  Therapy  
点击此处可从《中国癌症杂志》浏览原始摘要信息
点击此处可从《中国癌症杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号